S U M M A R Y Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) regulate extracellular matrix turnover throughout the body, including in renal glomeruli. We investigated protein levels of multiple MMPs (MMP-1, MMP-2, MMP-3, and MMP-9) and TIMP-1 in glomeruli and investigated whether disease phenotypes were associated with levels of these proteins. Renal cortex was collected from 100 adult autopsy subjects arrayed across 17 tissue microarrays. Immunohistochemical staining intensity for each MMP and TIMP-1 was determined using quantitative color deconvolution techniques. We observed significantly decreased glomerular MMP-1 and TIMP-1 staining in subjects with diabetes, hypertension, and an estimated glomerular filtration rate ,30 ml/min/1.73 m 2 in univariate analyses. MMP-1 staining, but not TIMP-1 staining, was inversely correlated with increased glomerular fibrosis (r 5 20.40). In multivariable analysis, diabetes was robustly associated with decreased staining intensity. This study indicates that in human subjects, the long-term sequelae of diseases such as diabetes that cause chronic renal failure result in decreased TIMP-1 and MMP-1 proteins in renal glomeruli. This manuscript contains online supplemental material at http://www.jhc.org. Please visit this article online to view these materials. . When an imbalance between activities of these two protein classes occurs, the result is often a pathological alteration of ECM. Numerous MMPs and TIMPs, including MMP-1, -2, -3, -9, and -13 and TIMP-1, -2, and -3 have been investigated within the kidney and implicated in progressive renal scarring (Lenz et al. 2000;Ahmed et al. 2007). Altered renal MMP and TIMP activity results in increased ECM deposition and/or decreased ECM breakdown (Lenz et al. 2000). Within the glomeruli, MMPs have been implicated in pathological matrix accumulation. Both non-inflammatory and inflammatory glomerular diseases alter MMP and TIMP expression levels, often in opposite directions (Reckelhoff et al. 1993;Nakamura et al. 1994Nakamura et al. ,1995Singhal et al. 1996). Despite numerous animal models that describe MMP and TIMP alterations in glomeruli, there have been very few studies in human subjects. We undertook this study to examine glomerular MMP and TIMP protein levels in kidneys taken from 100 adults with a broad range of chronic diseases. We hypothesized that hypertension and diabetes would be associated with lower MMP and higher TIMP protein levels, based on animal data. We used vascular tissue microarrays (TMAs) and color deconvolution techniques to characterize the amount of each protein in the glomeruli and correlated these measures with clinical variables (Cornish and Halushka in press; Halushka et al. in press).